Well I think it's certainly a possibility with Renascor but maybe it's not RNU is the problem. Maybe it's the sector. Not quite sexy enough just yet. I guess we'll see when they release that grade data. Should be soon.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
